Rituximab for Prevention of Rejection After Renal Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00565331
Recruitment Status : Completed
First Posted : November 29, 2007
Last Update Posted : November 10, 2015
Hoffmann-La Roche
Astellas Pharma GmbH
Information provided by (Responsible Party):
Radboud University